Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2025-12-26 @ 10:19 PM
NCT ID:
NCT06647212
Eligibility Criteria:
Inclusion Criteria:
patients participating in cardiac rehabilitation program
Exclusion Criteria:
* Decompensated heart failure, with symptoms in NYHA class II-IV within 3 weeks before admission to the Cardiac Rehabilitation Department
* Poorly controlled hypertension (BP in office measurement \>160/100 mmHg)
* Severe symptomatic heart disease (including valvular);
* Other severe comorbidities, including those significantly limiting physical performance: chronic kidney disease with GFR \<30 ml/min/1.73m2 (according to the CKD-EPI formula), severe form of bronchial asthma/chronic obstructive pulmonary disease (stage C/D ), hypertrophic cardiomyopathy, significant cardiac arrhythmias (persistent/permanent atrial fibrillation, sustained supraventricular/ventricular tachycardia, multiple supraventricular/ventricular extrasystole \> 10,000/day), pulmonary embolism in the last 3 months, acute coronary syndrome in the last 7 days, peripheral arterial disease with claudication distance \<200 m, generalized active neoplastic process;
* mental illness/dementia syndrome that prevents full cooperation with the examined person;
* diseases of the musculoskeletal system that make it impossible to perform an exercise test;
* contraindications to performing an exercise test;
* contact allergy to the materials from which the body/cover of the harmonica is made, revealed during exercises
* lack of consent to participate in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06647212
Study Brief:
Protocol Section:
NCT06647212